Back
Xylem Vs. Akero Therapeutics Industry Stock Comparison
Buy
62
XYL
Xylem
Last Price:
109.72
Seasonality Move:
4.8%
Buy
71
AKRO
Akero Therapeutics
Last Price:
52.46
Seasonality Move:
28.46%
Buy
62
Xylem (XYL)
is a Buy
Is Xylem a Buy, Sell or Hold?
- The current Xylem [XYL] share price is $109.71. The Score for XYL is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- XYL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $52.49. The Score for AKRO is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $52.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.
XYL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.02 | Buy |
| Relative Strength Index (14 RSI): | 67.8 | Buy |
| Chaikin Money Flow: | 1040983 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (101.37 - 107.59) | Buy |
| Bollinger Bands (100): | (100.1 - 106.66) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.96 | Buy |
| Relative Strength Index (14 RSI): | 67.52 | Buy |
| Chaikin Money Flow: | -176314 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.13 - 49.81) | Buy |
| Bollinger Bands (100): | (40.3 - 48.16) | Buy |
XYL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.71 | Buy |
| 20-day SMA: | 103.85 | Buy |
| 50-day SMA: | 103.97 | Buy |
| 200-day SMA: | 102.89 | Buy |
| 8-day EMA: | 106.4 | Buy |
| 20-day EMA: | 104.75 | Buy |
| 50-day EMA: | 104.01 | Buy |
| 200-day EMA: | 102.47 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.59 | Buy |
| 20-day SMA: | 47.06 | Buy |
| 50-day SMA: | 44.02 | Buy |
| 200-day SMA: | 40.68 | Buy |
| 8-day EMA: | 50.1 | Buy |
| 20-day EMA: | 47.78 | Buy |
| 50-day EMA: | 45.53 | Buy |
| 200-day EMA: | 39.27 | Buy |
Xylem Earnings Growth & XYL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.06 per share, an increase this year of $0.48 per share, and an increase next year of $0.37 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.76 per share.
Xylem Technical Analysis
| May-26 | May-30 | May-31 | Jun-1 | Jun-2 | Jun-5 | Jun-6 | Jun-7 | Jun-8 | Jun-9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 26 | 30 | 31 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| May-26 | May-30 | May-31 | Jun-1 | Jun-2 | Jun-5 | Jun-6 | Jun-7 | Jun-8 | Jun-9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 26 | 30 | 31 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||